Solifenacin Is Effective for the Treatment of OAB Dry Patients: A Pooled Analysis
- 30 September 2005
- journal article
- research article
- Published by Elsevier in European Urology
- Vol. 48 (3) , 483-487
- https://doi.org/10.1016/j.eururo.2005.06.007
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Solifenacin significantly improves all symptoms of overactive bladder syndromeInternational Journal Of Clinical Practice, 2006
- Long-Term Open-Label Solifenacin Treatment Associated with Persistence with Therapy in Patients with Overactive Bladder SyndromeEuropean Urology, 2005
- Improved quality of life in patients with overactive bladder symptoms treated with solifenacinBJU International, 2004
- The Impact of Urinary Urgency and Frequency on Health-Related Quality of Life in Overactive Bladder: Results from a National Community SurveyValue in Health, 2004
- TROSPIUM CHLORIDE IMPROVES OVERACTIVE BLADDER SYMPTOMS: A MULTICENTER PHASE III TRIALJournal of Urology, 2004
- Darifenacin, an M3 Selective Receptor Antagonist, is an Effective and Well-Tolerated Once-Daily Treatment for Overactive BladderEuropean Urology, 2004
- Management of Overactive BladderNew England Journal of Medicine, 2004
- Randomized, double‐blind placebo‐ and tolterodine‐controlled trial of the once‐daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladderBJU International, 2004
- Solifenacin appears effective and well tolerated in patients with symptomatic idiopathic detrusor overactivity in a placebo‐ and tolterodine‐controlled phase 2 dose‐finding studyBJU International, 2003
- Nocturia: A Risk Factor for Falls in the ElderlyJournal of the American Geriatrics Society, 1992